These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6202611)

  • 1. [HBs-antigen-positive chronic aggressive hepatitis].
    Müller R; Schmidt FW
    Fortschr Med; 1984 Apr; 102(16):449-54. PubMed ID: 6202611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New developments in therapy and prophylaxis of viral hepatitis (author's transl)].
    Thaler H
    Acta Med Austriaca; 1981; 7(2):43-8. PubMed ID: 6163300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of chronic active hepatitis caused by hepatitis B virus infection].
    Degos F; Marcellin P; Benhamou JP
    Gastroenterol Clin Biol; 1988 Nov; 12(11):845-54. PubMed ID: 2464521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].
    Zoulim F; Capel F; Berthillon P; Trépo C; Petit MA
    Gastroenterol Clin Biol; 1995 Dec; 19(12):970-5. PubMed ID: 8729407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus precore/core variation and interferon therapy.
    Fattovich G; McIntyre G; Thursz M; Colman K; Giuliano G; Alberti A; Thomas HC; Carman WF
    Hepatology; 1995 Nov; 22(5):1355-62. PubMed ID: 7590647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hepatitis B].
    Telegdy L
    Orv Hetil; 2004 Nov; 145(45):2293-6. PubMed ID: 15573894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously cured of hepatitis B].
    Romand F; Michallet M; Pichoud C; Trépo C; Zoulim F
    Gastroenterol Clin Biol; 1999; 23(6-7):770-4. PubMed ID: 10470533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic hepatitis-b-virus infections: new options for antiviral therapy].
    de Man RA; Honkoop P; Janssen HL; Schalm SW
    Ned Tijdschr Geneeskd; 1999 Sep; 143(37):1857-61. PubMed ID: 10526598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.
    Suzuki F; Tsubota A; Akuta N; Someya T; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Miyakawa Y; Kumada H
    J Gastroenterol; 2002; 37(11):922-7. PubMed ID: 12483247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatological update (7). 2 different phases of chronic hepatitis B--2 different methods of treatment?].
    Juszczyk J
    Pol Tyg Lek; 1987 Oct; 42(43):1365-8. PubMed ID: 3328179
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatitis B virus mutants--clinical significance].
    Blum HE; Moradpour D; vøn Weizsäcker F; Wieland S; Peters T; Rasenack JW
    Z Gastroenterol; 1997 May; 35(5):347-55. PubMed ID: 9265394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
    Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
    Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of hepatitis B vaccine in susceptible spouses of chronic hepatitis B virus infected individuals at the time of marriage.
    Roushan MR; Samie H; Amiri MJ
    Saudi Med J; 2007 Apr; 28(4):540-3. PubMed ID: 17457474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment.
    Feld JJ; Heathcote EJ
    Semin Liver Dis; 2006 May; 26(2):116-29. PubMed ID: 16673290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
    Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel treatment options for hepatitis B virus infection.
    Kumar R; Agrawal B
    Curr Opin Investig Drugs; 2004 Feb; 5(2):171-8. PubMed ID: 15043391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.
    Awerkiew S; Däumer M; Reiser M; Wend UC; Pfister H; Kaiser R; Willems WR; Gerlich WH
    J Clin Virol; 2007 Jan; 38(1):83-6. PubMed ID: 17134939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
    Wiegand J; Hasenclever D; Tillmann HL
    Antivir Ther; 2008; 13(2):211-20. PubMed ID: 18505172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination.
    Sjogren MH
    Am J Med; 2005 Oct; 118 Suppl 10A():34S-39S. PubMed ID: 16271539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.